Nicholas Laccona - Jan 26, 2022 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
FINANCIAL OFFICER, (PFO & PAO)
Signature
/s/ Nicholas Laccona
Stock symbol
BLPH
Transactions as of
Jan 26, 2022
Transactions value $
$0
Form type
4
Date filed
1/28/2022, 03:30 PM
Previous filing
Oct 8, 2021
Next filing
Dec 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Restricted Stock Units Award $0 +36K $0.00 36K Jan 26, 2022 Common Stock 36K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
F2 Not applicable.